These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 16145371)
1. Prognostic role of Fuhrman grade and vascular endothelial growth factor in pT1a clear cell carcinoma in partial nephrectomy specimens. Minardi D; Lucarini G; Mazzucchelli R; Milanese G; Natali D; Galosi AB; Montironi R; Biagini G; Muzzonigro G J Urol; 2005 Oct; 174(4 Pt 1):1208-12. PubMed ID: 16145371 [TBL] [Abstract][Full Text] [Related]
2. Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up. Minardi D; Lucarini G; Filosa A; Milanese G; Zizzi A; Di Primio R; Montironi R; Muzzonigro G Int J Immunopathol Pharmacol; 2008; 21(2):447-55. PubMed ID: 18547492 [TBL] [Abstract][Full Text] [Related]
3. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy. Lau WK; Cheville JC; Blute ML; Weaver AL; Zincke H Urology; 2002 Apr; 59(4):532-7. PubMed ID: 11927308 [TBL] [Abstract][Full Text] [Related]
4. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma. Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498 [TBL] [Abstract][Full Text] [Related]
5. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma. Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of platelet-derived growth factor receptor-β expression in localized clear cell renal cell carcinoma. Shim M; Song C; Park S; Choi SK; Cho YM; Kim CS; Ahn H J Cancer Res Clin Oncol; 2015 Dec; 141(12):2213-20. PubMed ID: 26215891 [TBL] [Abstract][Full Text] [Related]
8. Thrombospondin-1, vascular endothelial growth factor expression and microvessel density in renal cell carcinoma and their relationship with multifocality. Baltaci S; Orhan D; Göğüş C; Filiz E; Tulunay O; Göğüş O Eur Urol; 2003 Jul; 44(1):76-81; discussion 81. PubMed ID: 12814678 [TBL] [Abstract][Full Text] [Related]
9. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series. Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ; BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519 [TBL] [Abstract][Full Text] [Related]
10. Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival. Carini M; Minervini A; Lapini A; Masieri L; Serni S J Urol; 2006 Jun; 175(6):2022-6; discussion 2026. PubMed ID: 16697790 [TBL] [Abstract][Full Text] [Related]
11. Sarcomatoid features, necrosis, and grade are prognostic factors in metastatic clear cell renal cell carcinoma with vascular endothelial growth factor-targeted therapy. Park JY; Lee JL; Baek S; Eo SH; Go H; Ro JY; Cho YM Hum Pathol; 2014 Jul; 45(7):1437-44. PubMed ID: 24784922 [TBL] [Abstract][Full Text] [Related]
12. Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in patients with clear cell renal cell carcinoma. Minardi D; Santoni M; Lucarini G; Mazzucchelli R; Burattini L; Conti A; Bianconi M; Scartozzi M; Milanese G; Primio RD; Montironi R; Cascinu S; Muzzonigro G Urol Oncol; 2015 Mar; 33(3):113.e1-7. PubMed ID: 25069421 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma. Yoo C; Song C; Hong JH; Kim CS; Ahn H J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101 [TBL] [Abstract][Full Text] [Related]
14. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma. Dall'Oglio MF; Ribeiro-Filho LA; Antunes AA; Crippa A; Nesrallah L; Gonçalves PD; Leite KR; Srougi M J Urol; 2007 Aug; 178(2):425-8; discussion 428. PubMed ID: 17561167 [TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Bui MH; Seligson D; Han KR; Pantuck AJ; Dorey FJ; Huang Y; Horvath S; Leibovich BC; Chopra S; Liao SY; Stanbridge E; Lerman MI; Palotie A; Figlin RA; Belldegrun AS Clin Cancer Res; 2003 Feb; 9(2):802-11. PubMed ID: 12576453 [TBL] [Abstract][Full Text] [Related]
16. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma. Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177 [TBL] [Abstract][Full Text] [Related]
17. A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Leibovich BC; Cheville JC; Lohse CM; Zincke H; Frank I; Kwon ED; Merchan JR; Blute ML J Urol; 2005 Nov; 174(5):1759-63; discussion 1763. PubMed ID: 16217278 [TBL] [Abstract][Full Text] [Related]
18. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project). Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V; Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912 [TBL] [Abstract][Full Text] [Related]
19. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients. Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127 [TBL] [Abstract][Full Text] [Related]
20. Tumor size and Fuhrman grade further enhance the prognostic impact of perinephric fat invasion and renal vein extension in T3a staging of renal cell carcinoma. Chen K; Lee BL; Huang HH; Tan BY; Lee LS; Ng LG; Lau W; Yuen JS Int J Urol; 2017 Jan; 24(1):51-58. PubMed ID: 27757999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]